distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
Published 1 year ago • 66 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
2:53
autohct in dlbcl in the car-t era
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
6:50
analyze and take action on surveillance data
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:02:50
iso 27001 2022 information security management system | webinar
-
6:29
collection center rate list: step-by-step guide in #1 onelabz healthcare management system
-
3:45
cell saver elite-01耗材安裝
-
3:21
safety management of car-t cell therapy in dlbcl
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
7:16
changes in the classification of dlbcl
-
2:11
iec 60601-1 ed 3.1 - background and introduction
-
3:04
applying molecular understanding of dlbcl to management strategies
-
6:28
outcomes following first-line therapy in routine clinical practice in alcl
-
10:41
trial updates in follicular lymphoma from ash 2019
-
6:14
horizon scan of car-t for lymphoma
-
6:29
hatch d1 - evaluating medicare data to evaluate paclitaxel-coated device safety - dr. secemsky
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
17:32
overview of pre-identification on oeaa secure site
-
1:15
personalized medicine for dlbcl
-
2:43
gemtuzumab ozogamicin in frontline aml therapy